Mode
Text Size
Log in / Sign up

Somatropin

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Somatropin

27 trials tracked of Somatropin: 16 in phase 3 or 4 and 6 with published results. The most-cited published study has 102 citations.

27Trials tracked
16Phase 3 & 4
0Recruiting
6With published results
Phase distribution
Phase 4 2 Phase 3 14 Phase 2 3 Phase 1 2 Other / NA 6
  1. Phase 3 Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children Completed · 102 cited
  2. Phase 3 Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency. Completed · 79 cited
  3. Phase 3 Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome Completed · 24 cited
  4. Phase 3 A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency Completed · 15 cited
  5. Phase 3 Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy Completed · 6 cited
  6. Phase 3 Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature Completed · 5 cited
Show 21 more trials
  1. Phase 4 A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency Completed
  2. Phase 4 rHGH and Intestinal Permeability in Intestinal Failure Completed
  3. Phase 3 Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature Completed
  4. Phase 3 Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq Completed
  5. Phase 3 A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency Completed
  6. Phase 3 Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency Completed
  7. Phase 3 Somatropin Treatment to Final Height in Turner Syndrome Completed
  8. Phase 3 Growth Retardation In Children With Special Pathological Conditions Or Disease Completed
  9. Phase 3 Growth Hormone Treatment in Children Born Small for Gestational Age (SGA) Completed
  10. Phase 3 Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm Completed
  11. Phase 2 Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children Completed
  12. Phase 2 Evaluation of rGH Therapy to Prevent Muscle Atrophy in Patients With ACL Tears Completed
  13. Phase 2 Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age Completed
  14. Phase 1 Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents Completed
  15. Phase 1 Study of Testosterone and rHGH in FSHD Completed
  16. N/A Observational Study of Somatropin Treatment in Children Completed
  17. N/A Long Term Use of Somatropin in Patients Small for Gestational Age Completed
  18. N/A National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nutropin Depot, and Protropin Completed
  19. N/A Drug Use Investigation of Somatropin for GHD-ADULTS. Completed
  20. N/A Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese" Completed
  21. N/A A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults Completed

Showing the 27 most-cited and recently-updated of 27 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.